We are live on ! Find out more
NMTC icon

NeuroOne Medical Technologies

34 hedge funds and large institutions have $12.8M invested in NeuroOne Medical Technologies in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

39% more capital invested

Capital invested by funds: $9.18M → $12.8M (+$3.62M)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

13% more funds holding

Funds holding: 3034 (+4)

0.27% more ownership

Funds ownership: 4.53%4.8% (+0.27%)

Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
8
Reduced
7
Closed
5
Calls
$67K
Puts
Net Calls
+$67K
Net Calls Change
-$19K

NMTC Hedge Fund Activity: Q3 2025 in Review

34 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q3 2025, worth a combined $12.8M — up 39% from $9.18M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NMTC positions and 5 closed out — a net gain of 4 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was AWM Investment Company, opening a new position worth an estimated $748K. The largest seller was Sio Capital Management, cutting an estimated $949K.

  • 34 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q3 2025, up from 30 in Q2 2025.
  • Funds reported $12.8M of NeuroOne Medical Technologies stock for Q3 2025, up 39% quarter-over-quarter.
  • 9 funds opened new NeuroOne Medical Technologies positions in Q3 2025 and 5 closed out, a net change of +4 holders.
  • The largest NeuroOne Medical Technologies buyer in Q3 2025 was AWM Investment Company, an estimated $748K added.
  • The largest NeuroOne Medical Technologies seller in Q3 2025 was Sio Capital Management, an estimated $949K sold.

Based on aggregated 13F filings for Q3 2025.